Deng Hongkui
Deng Hongkui is a distinguished cellular biologist leading a research team at Peking University, known for groundbreaking work in regenerative medicine and diabetes treatment. He recently gained international attention for leading a successful clinical trial where a 25-year-old woman with type 1 diabetes started producing her own insulin after receiving a transplant of her own reprogrammed cells, marking a significant milestone in the potential treatment of this challenging autoimmune disease.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| China | 2 | 8.00 | 0.13% | +0% | 1,402,112,000 | 1,848,533 | $14,000,000 | 18,457$ |
| Totals | 2 | 1,402,112,000 | 1,848,533 | $14,000,000 | 18,457$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
China:
Deng Hongkui's team has developed a new technology for reprogramming human cells for regenerative medicine.
8
China:
Deng Hongkui's team has developed a new technology for reprogramming human cells, aiding in regenerative medicine.
8
Mexico:
Deng Hongkui led a team at Peking University that successfully transplanted reprogrammed cells into a woman with diabetes type 1.
9